Following in the footsteps of Eli Lilly and Roche, Sanofi has quietly received FDA clearance for a smartphone app with a built-in insulin dose calculator. According to FDA documents, the app, cleared ...

Lyumjev (insulin lispro-aabc) is prescribed to manage blood sugar levels in certain people with type 1 or 2 diabetes. The drug comes as a liquid solution for injection as directed by your doctor. The ...

Artificial intelligence (AI) can match physician insulin dosing, maintaining target blood sugar levels in patients with type 2 diabetes. A study showed an AI-based insulin decision support system's ...

Researchers tested the drug on 40 adults with long-term type 1 diabetes in the Insulin Resistance in Type 1 Diabetes Managed ...

Afrezza (insulin human) is a brand-name inhaled insulin prescribed to manage blood sugar in adults with diabetes. It comes as a powder that you typically take at mealtimes. The dosage can vary based ...

The study compared Foundayo with insulin glargine in more than 2,700 adults with type 2 diabetes. ・Patients taking Foundayo ...

Eli Lilly and Co (NYSE:LLY) released Thursday topline results from two phase 3 trials. The drugmaker evaluated once-weekly insulin efsitora alfa (efsitora) in type 2 diabetes patients using insulin ...

Most types of insulin therapy, an important part of diabetes treatment for many people, are given as daily injections to help manage blood sugar levels. Now, the maker of a once-weekly insulin ...

Concerns over hypoglycemia risk with an investigational once-weekly insulin product in patients with type 1 diabetes prompted the FDA to call an advisory committee together to weigh in on the matter.

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday. An interoperable automated glycemic controller, Insulet's SmartAdjust ...

Indianapolis-based pharma company Eli Lilly recently recieved FDA 510K clearance for a new mobile app called Go Dose, a diabetes management and insulin dosing app for users of Humalog, Lilly's ...